A detailed history of Sound Income Strategies, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Sound Income Strategies, LLC holds 22 shares of MYGN stock, worth $388. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22
Previous 22 -0.0%
Holding current value
$388
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 10, 2024

SELL
$13.91 - $21.32 $1,391 - $2,132
-100 Reduced 81.97%
22 $0
Q2 2022

Jul 11, 2022

BUY
$16.45 - $25.88 $2,006 - $3,157
122 New
122 $2,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.42B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Sound Income Strategies, LLC Portfolio

Follow Sound Income Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sound Income Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sound Income Strategies, LLC with notifications on news.